Literature DB >> 6328512

Extensive homology exists between Marek disease herpesvirus and its vaccine virus, herpesvirus of turkeys.

C P Gibbs, K Nazerian, L F Velicer, H J Kung.   

Abstract

Marek disease is a lymphomatous disease of chickens caused by infection of a herpesvirus, Marek disease virus (MDV). Marek disease is the only neoplastic disease for which a successful vaccine has been developed. The vaccine virus, herpesvirus of turkeys (HVT), is non-oncogenic in chickens. Despite the strong antigenic relationship between these viruses, previous studies showed that the two viral DNAs share little or no homology. Using less stringent hybridization conditions and methods that greatly improve the reassociation kinetics, we have reexamined the sequence homology between MDV and HVT DNA. We report here that HVT and MDV are far more closely related than previously reported. The homology between these two viral DNAs ranges between 70% and 80% at the nucleotide level and appears to extend over 90-95% of the respective genomes. Under the low stringency conditions used, MDV DNA fails to cross-hybridize with DNA from feline rhinotracheitis virus, an antigenically unrelated herpesvirus with a G-C content identical to that of MDV and HVT.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328512      PMCID: PMC345508          DOI: 10.1073/pnas.81.11.3365

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Minor DNA homology between herpesvirus of turkey and Marek's disease virus?

Authors:  Y S Lee; A Tanaka; S Silver; M Smith; M Nonoyama
Journal:  Virology       Date:  1979-02       Impact factor: 3.616

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Comparative studies on Marek's disease virus and herpesvirus of turkey DNAs.

Authors:  K Hirai; K Ikuta; S Kato
Journal:  J Gen Virol       Date:  1979-10       Impact factor: 3.891

4.  No homology detectable between Marek's disease virus (MDV) DNA and herpesvirus of the turkey (HVT) DNA.

Authors:  C Kaschka-Dierich; G W Bornkamm; R Thomssen
Journal:  Med Microbiol Immunol       Date:  1979-01-24       Impact factor: 3.402

5.  Continuous cell culture from lymphoma of Marek's disease.

Authors:  Y Akiyama; S Kato; N Iwa
Journal:  Biken J       Date:  1973-12

6.  Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus.

Authors:  R L Witter; K Nazerian; H G Purchase; G H Burgoyne
Journal:  Am J Vet Res       Date:  1970-03       Impact factor: 1.156

7.  Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen.

Authors:  C Glaubiger; K Nazerian; L F Velicer
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

8.  A rapid method for detecting and mapping homology between heterologous DNAs. Evaluation of polyomavirus genomes.

Authors:  P M Howley; M A Israel; M F Law; M A Martin
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

9.  Immunofluorescence in the study of Marek's disease. I. Detection of antigen in cell culture and an antigenic comparison of eight isolates.

Authors:  H G Purchase
Journal:  J Virol       Date:  1969-06       Impact factor: 5.103

10.  Most virus-specific polypeptides in cells productively infected with Marek's disease virus or herpesvirus of turkeys possess cross-reactive determinants.

Authors:  K Ikuta; S Ueda; S Kato; K Hirai
Journal:  J Gen Virol       Date:  1983-04       Impact factor: 3.891

View more
  17 in total

1.  The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus.

Authors:  L F Lee; P Wu; D Sui; D Ren; J Kamil; H J Kung; R L Witter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Identification of viral proteins encoded by two DNA fragments of herpesvirus of turkeys (HVT).

Authors:  H Levy; T Maray; I Davidson; M Malkinson; Y Becker
Journal:  Virus Genes       Date:  1991-07       Impact factor: 2.332

3.  Identification of the gene encoding Marek's disease herpesvirus A antigen.

Authors:  R J Isfort; H J Kung; L F Velicer
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

4.  Map location of homologous regions between Marek's disease virus and herpesvirus of turkey and the absence of detectable homology in the putative tumor-inducing gene.

Authors:  K Fukuchi; M Sudo; A Tanaka; M Nonoyama
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage.

Authors:  R F Silva; R L Witter
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

Review 6.  Warner-Lambert/Parke-Davis Award Lecture. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genes.

Authors:  D P Hajjar
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

7.  Similarities and dissimilarities in the structure and expression of viral genomes of various virus strains immunologically related to Marek's disease virus.

Authors:  K Hirai; K Nakajima; K Ikuta; R Kirisawa; Y Kawakami; T Mikami; S Kato
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

8.  Genetic and biochemical characterization of the thymidine kinase gene from herpesvirus of turkeys.

Authors:  S L Martin; D I Aparisio; P K Bandyopadhyay
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

9.  Impact of deletions within the Bam HI-L fragment of attenuated Marek's disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4.

Authors:  Keith William Jarosinski; Priscilla Helene O'Connell; Karel Antoni Schat
Journal:  Virus Genes       Date:  2003-05       Impact factor: 2.332

10.  Cell culture amplification of a defective Marek's disease virus.

Authors:  J K Carter; R F Silva
Journal:  Virus Genes       Date:  1990-09       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.